1. INTRODUCTION
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. ALPHA AMYLASE MARKET ANALYSIS, BY SOURCE
5.1. Introduction
5.2. Fungi
5.3. Maltogenic
5.4. G4
5.5. Other Bacteria and Plant Based
6. ALPHA AMYLASE MARKET ANALYSIS, BY APPLICATION
6.1. Introduction
6.2. Bread
6.3. Cookies & Biscuits
6.4. Desserts
6.5. Others
7. ALPHA AMYLASE MARKET, BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. United Kingdom
7.4.4. Spain
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. Japan
7.6.3. South Korea
7.6.4. India
7.6.5. Taiwan
7.6.6. Thailand
7.6.7. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. COMPANY PROFILES
9.1. Worthington Biochemical Corporation
9.2. BIO-CAT Company
9.3. American Biosystems, Inc.
9.4. LALLEMAND Inc.
9.5. Gusmer Enterprises, Inc.
9.6. Tokyo Chemical Industry Co., Ltd
9.7. Novozymers
9.8. Aumgene Biosciences Lee BioSolutions
9.9. AB Amylase
9.10. Infinita Biotech Private Limited